These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 36065779)
1. Cardio-oncology: Understanding the different mechanisms of cardiovascular toxicity. Toste JC Rev Port Cardiol; 2022 Jul; 41(7):587-597. PubMed ID: 36065779 [TBL] [Abstract][Full Text] [Related]
2. Organization and implementation of a cardio-oncology program. Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589 [TBL] [Abstract][Full Text] [Related]
3. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology. Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257 [TBL] [Abstract][Full Text] [Related]
4. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention. Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943 [TBL] [Abstract][Full Text] [Related]
5. Antineoplastic drugs inducing cardiac and vascular toxicity - An update. Barachini S; Ghelardoni S; Varga ZV; Mehanna RA; Montt-Guevara MM; Ferdinandy P; Madonna R Vascul Pharmacol; 2023 Dec; 153():107223. PubMed ID: 37678516 [TBL] [Abstract][Full Text] [Related]
6. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569 [TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921 [TBL] [Abstract][Full Text] [Related]
8. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity. O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285 [TBL] [Abstract][Full Text] [Related]
9. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey. Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180 [TBL] [Abstract][Full Text] [Related]
10. [Cardiotoxicity of Cancer Chemotherapy - Mechanisms and Therapeutic Approach]. Akazawa H Gan To Kagaku Ryoho; 2017 Dec; 44(13):2058-2063. PubMed ID: 29361617 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. Yeh ETH; Ewer MS; Moslehi J; Dlugosz-Danecka M; Banchs J; Chang HM; Minotti G Semin Oncol; 2019 Dec; 46(6):397-402. PubMed ID: 31753424 [TBL] [Abstract][Full Text] [Related]
12. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology. Liang Z; He Y; Hu X Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142538 [TBL] [Abstract][Full Text] [Related]
13. Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs. Beyer AM; Bonini MG; Moslehi J Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H164-H167. PubMed ID: 31172808 [TBL] [Abstract][Full Text] [Related]